Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?
about
Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future PossibilitiesPredictors and prognostic implications of major adverse cardiovascular events after renal transplant: 10 years outcomes in 321 patientsCoronary artery bypass graft type and outcomes in maintenance dialysis.Impact of moderate to severe renal impairment on mortality and appropriate shocks in patients with implantable cardioverter defibrillatorsPrevention of sudden cardiac death in patients with chronic kidney disease.Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.Electrocardiogram abnormalities and heart rate variability in predicting mortality and cardiovascular events among hemodialyzed patients.Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial.Cause of Death in Patients with Reduced Kidney Function.Association between Clinical and Doppler Echocardiographic Parameters with Sudden Death in Hemodialysis Patients.Sudden cardiac death in chronic kidney disease: epidemiology and prevention.Sudden cardiac arrest and sudden cardiac death on dialysis: Epidemiology, evaluation, treatment, and prevention.Prevention of sudden cardiac death in dialysis patients: drugs, defibrillators or what else.Risk of sudden cardiac death in chronic kidney disease.Sudden cardiac death in haemodialysis patients: preventative options.Sudden cardiac death in end stage renal disease: unlocking the mystery.The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease.Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis.The effect of uraemia on the duration of arrhythmias in the context of cardioprotective ischaemic conditioning strategies.Cardiac catheterization in the dialysis population in 2012: we know more, but much remains unknown.Bad kidneys are bad for the heart: but what can we do about it?Sudden cardiac death in dialysis: do current guidelines for implantable cardioverter defibrillator therapy apply to patients with end-stage kidney disease?Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.Cardiac Remodelling in Patients Undergoing in-Centre Nocturnal Haemodialysis: Results from the MIDNIGHT Study, a Non-Randomized Controlled Trial.Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study.The intuitive case for β-blockers in patients with ESRD.Syncope and Collapse Are Associated with an Increased Risk of Cardiovascular Disease and Mortality in Patients Undergoing Dialysis
P2860
Q30360334-B926E495-9AB7-4AE6-ABE0-AE63C2674CF3Q33848014-37323EAD-D8CE-4901-9A52-485FC10653CFQ34052895-DAE1AEAB-903F-49CC-B34C-4AB57FBC45B3Q34442569-94AFDFE8-3F23-43B5-A0D4-87EE37B81AC8Q34498672-BE905AED-971C-4AFD-AA15-161D8C6ECDC7Q34820403-55F5D768-A4AA-49FE-A6BF-5E0210225326Q34857667-09F44FC6-DADA-4E46-A0B0-E65D4C1B0DE3Q35761655-A4B9F8FB-68BC-4557-BB7E-80B3AB948549Q36071494-FD694766-EF20-4282-96C8-5839B93DB25EQ36104829-1B25B6EB-93B5-488F-9BD6-505C0CC3F134Q37357070-76169000-A10A-462A-8694-BA2A0E7F4BE7Q37833896-A4222DF1-E816-4AAF-87DD-5E99E729CDDDQ37957416-968E6076-35AB-476D-87BD-5EA076C41133Q38076218-318F7159-B65E-4A43-B366-FF56BBA6B5C9Q38164437-D584A505-7FF5-4114-89AB-5BE93FF283C3Q38250885-0E4A7C58-C3C9-4832-B027-C14128477685Q38267707-2ADE044C-B3F4-4B6F-AE2C-3674F64952B2Q38635835-ED4E4FD9-460F-4435-947F-CC2E3FC9463CQ38672873-A3C41A83-5192-4FF0-A5F3-842DDA577947Q39460532-DC96ECF4-EE84-4B6A-9D62-23BB970CA7CFQ39667593-80CE931D-66C7-4D36-8F16-C4CF022EFF68Q43579513-73DF8F8A-0AD3-4F24-A7E3-5881D4E69FB7Q44318647-4B7495E5-F5EB-4F51-A43E-5A289AD94371Q45801526-52E4799B-2C62-43B8-BB26-CA837D1DA71BQ46944476-E48E6639-F198-498F-A3F6-67F82B0E116BQ50223912-D49C05A5-49FF-40E3-B609-81C2AD9153C3Q51353168-64CD2A3B-55D3-4553-A2A1-7FC925CA91C8Q51636115-522339D0-520D-4A48-9DA2-25F05C56D752Q58702466-063EA9C3-4E5B-4CDB-A421-C044FA0ABAFA
P2860
Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cause-specific mortality of di ...... l after coronary intervention?
@en
Cause-specific mortality of di ...... l after coronary intervention?
@nl
type
label
Cause-specific mortality of di ...... l after coronary intervention?
@en
Cause-specific mortality of di ...... l after coronary intervention?
@nl
prefLabel
Cause-specific mortality of di ...... l after coronary intervention?
@en
Cause-specific mortality of di ...... l after coronary intervention?
@nl
P2093
P2860
P356
P1476
Cause-specific mortality of di ...... l after coronary intervention?
@en
P2093
Allan J Collins
Charles A Herzog
David T Gilbertson
Jeremy W Strief
P2860
P304
P356
10.1093/NDT/GFN038
P407
P577
2008-02-25T00:00:00Z